BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Landau YE, Lichter-Konecki U, Levy HL. Genomics in newborn screening. J Pediatr 2014;164:14-9. [PMID: 23992678 DOI: 10.1016/j.jpeds.2013.07.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Murdock DR, Donovan FX, Chandrasekharappa SC, Banks N, Bondy C, Muenke M, Kruszka P. Whole-Exome Sequencing for Diagnosis of Turner Syndrome: Toward Next-Generation Sequencing and Newborn Screening. J Clin Endocrinol Metab 2017;102:1529-37. [PMID: 28324009 DOI: 10.1210/jc.2016-3414] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
2 Downie L, Halliday J, Lewis S, Amor DJ. Principles of Genomic Newborn Screening Programs: A Systematic Review. JAMA Netw Open 2021;4:e2114336. [PMID: 34283230 DOI: 10.1001/jamanetworkopen.2021.14336] [Reference Citation Analysis]
3 Reinstein E. Challenges of using next generation sequencing in newborn screening. Genet Res (Camb) 2015;97:e21. [PMID: 26521961 DOI: 10.1017/S0016672315000178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
4 Friedman JM, Cornel MC, Goldenberg AJ, Lister KJ, Sénécal K, Vears DF; Global Alliance for Genomics and Health Regulatory and Ethics Working Group Paediatric Task Team. Genomic newborn screening: public health policy considerations and recommendations. BMC Med Genomics 2017;10:9. [PMID: 28222731 DOI: 10.1186/s12920-017-0247-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
5 Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals' opinions of whole-genome sequencing in the newborn period. J Genet Couns 2015;24:452-63. [PMID: 25348082 DOI: 10.1007/s10897-014-9779-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Roberts MC, Fohner AE, Landry L, Olstad DL, Smit AK, Turbitt E, Allen CG. Advancing precision public health using human genomics: examples from the field and future research opportunities. Genome Med 2021;13:97. [PMID: 34074326 DOI: 10.1186/s13073-021-00911-0] [Reference Citation Analysis]
7 Hao C, Guo R, Hu X, Qi Z, Guo Q, Liu X, Liu Y, Sun Y, Zhang X, Jin F, Wu X, Cai R, Zeng D, Hu X, Wang X, Ji X, Li W, Xing Q, Mu L, Jiang X, Yang X, Yang W, Zhang Y, Yin Q, Ni X, Li W. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China. J Genet Genomics 2021:S1673-8527(21)00280-0. [PMID: 34474183 DOI: 10.1016/j.jgg.2021.08.008] [Reference Citation Analysis]
8 Gannavarapu S, Prasad C, DiRaimo J, Napier M, Goobie S, Potter M, Chakraborty P, Karaceper M, Munoz T, Schulze A, MacKenzie J, Li L, Geraghty MT, Al-Dirbashi OY, Rupar CA. Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007-2014). Mol Genet Metab 2015;116:146-51. [PMID: 26361991 DOI: 10.1016/j.ymgme.2015.08.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
9 Meller R. Addressing Benefits, Risks and Consent in Next Generation Sequencing Studies. J Clin Res Bioeth 2015;6:249. [PMID: 27375922 DOI: 10.4172/2155-9627.1000249] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Martínez-morillo E, Prieto García B, Álvarez Menéndez FV. Challenges for Worldwide Harmonization of Newborn Screening Programs. Clinical Chemistry 2016;62:689-98. [DOI: 10.1373/clinchem.2015.240903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Amor DJ. Future of whole genome sequencing: The future of whole genome sequencing. J Paediatr Child Health 2015;51:251-4. [DOI: 10.1111/jpc.12634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Levy HL. Newborn screening: the genomic challenge. Mol Genet Genomic Med 2014;2:81-4. [PMID: 24689069 DOI: 10.1002/mgg3.74] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
13 Modell SM, Kardia SL, Citrin T. Stakeholder consultation insights on the future of genomics at the clinical-public health interface. Transl Res 2014;163:466-77. [PMID: 24434657 DOI: 10.1016/j.trsl.2013.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cho Y, Lee CH, Jeong EG, Kim MH, Hong JH, Ko Y, Lee B, Yun G, Kim BJ, Jung J, Jung J, Lee JS. Prevalence of Rare Genetic Variations and Their Implications in NGS-data Interpretation. Sci Rep 2017;7:9810. [PMID: 28851938 DOI: 10.1038/s41598-017-09247-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
15 Rajabi F, Levy HL. Expansion and Implications of Newborn Screening. Curr Genet Med Rep 2015;3:110-7. [DOI: 10.1007/s40142-015-0070-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Rajabi F. Updates in Newborn Screening. Pediatr Ann 2018;47. [DOI: 10.3928/19382359-20180426-01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing. Pediatrics 2016;137 Suppl 1:S36-46. [PMID: 26729702 DOI: 10.1542/peds.2015-3731H] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
18 Beckmann JS. Can we afford to sequence every newborn baby's genome? Hum Mutat 2015;36:283-6. [PMID: 25546530 DOI: 10.1002/humu.22748] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
19 Blau N, Shen N, Carducci C. Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn 2014;14:655-71. [PMID: 24882081 DOI: 10.1586/14737159.2014.923760] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
20 Karki R, Pandya D, Elston RC, Ferlini C. Defining "mutation" and "polymorphism" in the era of personal genomics. BMC Med Genomics 2015;8:37. [PMID: 26173390 DOI: 10.1186/s12920-015-0115-z] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 8.9] [Reference Citation Analysis]
21 Iacobazzi V, Infantino V, Castegna A, Andria G. Hyperhomocysteinemia: Related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. Molecular Genetics and Metabolism 2014;113:27-33. [DOI: 10.1016/j.ymgme.2014.07.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
22 Eichinger J, Elger BS, Koné I, Filges I, Shaw D, Zimmermann B, McLennan S. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021;21:387. [PMID: 34488686 DOI: 10.1186/s12887-021-02830-w] [Reference Citation Analysis]
23 Landau YE, Waisbren SE, Chan LMA, Levy HL. Long-term outcome of expanded newborn screening at Boston children’s hospital: benefits and challenges in defining true disease. J Inherit Metab Dis 2017;40:209-18. [DOI: 10.1007/s10545-016-0004-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Borghesi A, Mencarelli MA, Memo L, Ferrero GB, Bartuli A, Genuardi M, Stronati M, Villani A, Renieri A, Corsello G; their respective Scientific Societies. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant. Ital J Pediatr 2017;43:100. [PMID: 29100554 DOI: 10.1186/s13052-017-0418-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 6.6] [Reference Citation Analysis]
25 Hohenfellner K, Bergmann C, Fleige T, Janzen N, Burggraf S, Olgemöller B, Gahl WA, Czibere L, Froschauer S, Röschinger W, Vill K, Harms E, Nennstiel U. Molecular based newborn screening in Germany: Follow-up for cystinosis. Mol Genet Metab Rep 2019;21:100514. [PMID: 31641587 DOI: 10.1016/j.ymgmr.2019.100514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 El Hadi C, Ayoub G, Bachir Y, Haykal M, Jalkh N, Kourie HR. Polygenic and Network-Based Studies in Risk Identification and Demystification of cancer. Expert Rev Mol Diagn 2022. [PMID: 35400274 DOI: 10.1080/14737159.2022.2065195] [Reference Citation Analysis]
27 Peterlin A, Petrovič D, Peterlin B. Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine. Curr Vasc Pharmacol 2019;17:25-8. [PMID: 29412113 DOI: 10.2174/1570161116666180206111725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Yang L, Chen J, Shen B. Newborn Screening in the Era of Precision Medicine. In: Shen B, editor. Translational Informatics in Smart Healthcare. Singapore: Springer; 2017. pp. 47-61. [DOI: 10.1007/978-981-10-5717-5_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
29 Wang H, Yang Y, Zhou L, Wang Y, Long W, Yu B. NeoSeq: a new method of genomic sequencing for newborn screening. Orphanet J Rare Dis 2021;16:481. [PMID: 34794485 DOI: 10.1186/s13023-021-02116-5] [Reference Citation Analysis]
30 King JS, Smith ME. Whole-Genome Screening of Newborns? The Constitutional Boundaries of State Newborn Screening Programs. Pediatrics 2016;137 Suppl 1:S8-15. [PMID: 26729704 DOI: 10.1542/peds.2015-3731D] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
31 Levy HL. Ethical and Psychosocial Implications of Genomic Newborn Screening. Int J Neonatal Screen 2021;7:2. [PMID: 33435408 DOI: 10.3390/ijns7010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Smon A, Repic Lampret B, Groselj U, Zerjav Tansek M, Kovac J, Perko D, Bertok S, Battelino T, Trebusak Podkrajsek K. Next generation sequencing as a follow-up test in an expanded newborn screening programme. Clin Biochem 2018;52:48-55. [PMID: 29111448 DOI: 10.1016/j.clinbiochem.2017.10.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
33 Milko LV, O'Daniel JM, DeCristo DM, Crowley SB, Foreman AKM, Wallace KE, Mollison LF, Strande NT, Girnary ZS, Boshe LJ, Aylsworth AS, Gucsavas-Calikoglu M, Frazier DM, Vora NL, Roche MI, Powell BC, Powell CM, Berg JS. An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening. J Pediatr 2019;209:68-76. [PMID: 30851990 DOI: 10.1016/j.jpeds.2018.12.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
34 Richard E, Brasil S, Leal F, Navarrete R, Vega A, Ecay MJ, Desviat LR, Pérez-cerda C, Ugarte M, Merinero B, Pérez B. Isolated and Combined Remethylation Disorders: Biochemical and Genetic Diagnosis and Pathophysiology. Journal of Inborn Errors of Metabolism and Screening 2017;5:232640981668573. [DOI: 10.1177/2326409816685732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
35 Bhattacharjee A, Sokolsky T, Wyman SK, Reese MG, Puffenberger E, Strauss K, Morton H, Parad RB, Naylor EW. Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing. Genet Med 2015;17:337-47. [DOI: 10.1038/gim.2014.117] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
36 Trier C, Fournous G, Strand JM, Stray-Pedersen A, Pettersen RD, Rowe AD. Next-generation sequencing of newborn screening genes: the accuracy of short-read mapping. NPJ Genom Med 2020;5:36. [PMID: 32944285 DOI: 10.1038/s41525-020-00142-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Waisbren SE, Bäck DK, Liu C, Kalia SS, Ringer SA, Holm IA, Green RC. Parents are interested in newborn genomic testing during the early postpartum period. Genet Med 2015;17:501-4. [PMID: 25474344 DOI: 10.1038/gim.2014.139] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
38 Bodian DL, Klein E, Iyer RK, Wong WS, Kothiyal P, Stauffer D, Huddleston KC, Gaither AD, Remsburg I, Khromykh A, Baker RL, Maxwell GL, Vockley JG, Niederhuber JE, Solomon BD. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med 2016;18:221-30. [PMID: 26334177 DOI: 10.1038/gim.2015.111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 8.4] [Reference Citation Analysis]
39 DeCristo DM, Milko LV, O'Daniel JM, Foreman AKM, Mollison LF, Powell BC, Powell CM, Berg JS. Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making. Genome Med 2021;13:50. [PMID: 33781310 DOI: 10.1186/s13073-021-00867-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]